Lupin Limited has informed the Exchange regarding a press release dated October 13, 2023, titled "Lupin Receives Tentative Approval from U.S. FDA for Apalutamide Tablets.".
Lupin Limited has informed the Exchange regarding a press release dated October 13, 2023, titled "Lupin Receives Tentative Approval from U.S. FDA for Apalutamide Tablets.".